AI assistant
NEOGENOMICS INC — Director's Dealing 2014
Dec 19, 2014
32227_dirs_2014-12-19_851c21ab-c698-4a89-9b15-f18a1703ff41.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2014-12-18
Reporting Person: HOREL ROBERT H. (Vice President andGM PathLogic)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-12-18 | Common Stock | M | 17893 | $1.47 | Acquired | 17893 | Direct |
| 2014-12-18 | Common Stock | M | 5000 | $1.41 | Acquired | 22893 | Direct |
| 2014-12-18 | Common Stock | M | 40000 | $1.43 | Acquired | 62893 | Direct |
| 2014-12-18 | Common Stock | S | 62893 | $4.2003 | Disposed | 0 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-12-18 | Stock Option (Right to Buy) | $1.47 | X | 17893 | Acquired | 2016-12-25 | Common Stock (0) | Direct |
| 2014-12-18 | Stock Option (Right to buy) | $1.41 | X | 5000 | Acquired | 2015-03-04 | Common Stock (0) | Direct |
| 2014-12-18 | Stock Option (Right to buy) | $1.43 | X | 40000 | Acquired | 2015-04-20 | Common Stock (0) | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $0.62 | 2019-02-02 | Common Stock (0) | 4000 | Direct |
| Stock Option (Right to Buy) | $1.47 | 2017-02-12 | Common Stock (0) | 500 | Direct |
| Stock Option (Right to Buy) | $1.45 | 2016-05-19 | Common Stock (0) | 50000 | Direct |
| Stock Option (Right to Buy) | $1.69 | 2017-04-12 | Common Stock (0) | 25000 | Direct |
Footnotes
F1: On December 26, 2006 Mr. Horel was granted 30,000 stock options. There was immediate vesting of 4,000 shares and the remaining shares had a combination of time based and performance based vesting. There were 8,000 shares cancelled from this grant.
F2: On March 4, 2010 Mr. Horel was granted 5,000 stock options. These shares vested ratably over the first two anniversaries of the grant date.
F3: On April 20, 2010 Mr. Horel was granted 40,000 stock options. These shares vested ratably over the first two anniversaries of the grant date.
F4: On February 2, 2009 Mr. Horel was granted 6,000 stock options. These shares had performance based vesting and the first performance milestone was on December 31, 2009. There were 2,000 shares cancelled from this grant because of a missed performance milestone.
F5: On February 13, 2007 Mr. Horel was granted 500 stock options which had immediate vesting.
F6: On May 20, 2011 Mr. Horel was granted 50,000 stock options. These shares vest ratably over the first four anniversaries of the grant date.
F7: On April 12, 2012 Mr. Horel was granted 25,000 stock options. There was immediate vesting of 6,250 shares and then 6,250 shares will vest on each of the first three anniversaries of the grant date.